scholarly journals Development and characterization of an animal model of Japanese encephalitis virus infection in adolescent C57BL/6 mice

Author(s):  
Aarti Tripathi ◽  
Arup Banerjee ◽  
Sudhanshu Vrati

A mouse-adapted isolate of Japanese encephalitis virus (JEV), designated as JEV-S3, was generated by serially passaging the P20778 strain of the virus in 3-4 weeks old C57BL/6 mice. The blood-brain barrier leakage was evident in JEV-S3 infected mice, where viral antigens and RNA were consistently demonstrated in the brain and infiltration of activated immune cells as evidenced by an increased level of CD45+CD11b+ cell population. Histopathology studies showed the presence of perivascular cuffing, haemorrhage and necrotic foci in the virus-infected brain conforming to the pathological changes seen in the brain of JEV-infected patients. Mass spectrometry studies characterized the molecular events leading to brain inflammation in the infected mice. Notably, a significant induction of inflammatory cytokines such as IFN-γ, Il-6, TNF-α, and TGF-β was observed. Further, genome sequencing of the JEV-S3 isolate identified the mutations selected during the mouse passage of the virus. Overall, we present an in-depth characterization of a robust and reproducible mouse model of JEV infection. The JEV-S3 isolate will be a useful tool to screen antivirals and study the virus pathogenesis in the adolescent mouse model.

2003 ◽  
Vol 14 (2) ◽  
pp. 91-98 ◽  
Author(s):  
Shailendra Kumar Saxena ◽  
Asha Mathur ◽  
Ramesh Chandra Srivastava

Diethyldithiocarbamate (DDTC), a low molecular weight dithiol, has been described as an immunomodulator and modifier of diverse biological actions in human and animal models, and has also been shown to be effective in several disease conditions. Therefore, we studied the therapeutic aspect of DDTC in providing inhibition of Japanese encephalitis virus (JEV) infection. DDTC tested at various doses (10–100 μmol/kg) revealed that administration at low concentration (10 μmol/kg; i.p.) on alternate days prolonged the average survival time (AST) of mice infected with lethal dose of JEV (102 LD50, i.c.) and delayed progression of the disease. The low dose also provided >80% survival in sub-clinical (105 LD50, i.c.) JEV infection. Administration of DDTC to JEV-infected mice enhanced the inducible nitric oxide synthase (iNOS) activity in brain and level of serum tumour necrosis factor-α (TNF-α). We have recently demonstrated the production of nitric oxide (NO) via induction of iNOS activity is meditated by circulating macrophage-derived factor (MDF), which may be responsible for the delayed progression of the disease. DDTC-mediated inhibition of JEV is believed to involve the augmentation of protective role of MDF as evidenced by the observation that pretreatment with anti-MDF antibody significantly decreased the AST of mice and together with the inhibition of iNOS activity. Interestingly, DDTC alone did not stimulate iNOS and TNF-α in mock-infected normal mice. These results show that DDTC may have a possible therapeutic role during JEV infection.


2013 ◽  
Vol 57 (10) ◽  
pp. 723-731 ◽  
Author(s):  
Takashi Kimura ◽  
Megumi Okumura ◽  
Eunmi Kim ◽  
Michihito Sasaki ◽  
Yasuko Orba ◽  
...  

Neuroreport ◽  
2000 ◽  
Vol 11 (9) ◽  
pp. 1933-1937 ◽  
Author(s):  
Chun-Jung Chen ◽  
Su-Lan Liao ◽  
Ming-Der Kuo ◽  
Yu-Ming Wang

2018 ◽  
Vol 14 (7) ◽  
pp. e1007166 ◽  
Author(s):  
Hsin-Ping Chiu ◽  
Han Chiu ◽  
Chao-Fu Yang ◽  
Yi-Ling Lee ◽  
Feng-Lan Chiu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document